Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Total Voting Rights

2 Mar 2017 09:15

RNS Number : 3382Y
Science in Sport PLC
02 March 2017
 

2 March 2017

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

Total Voting Rights

Science in Sport plc (AIM: SIS), a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts, confirms that as at 28 February 2017, the Company had 43,375,427 ordinary shares of 10 pence each ("Ordinary Shares") in issue, with one voting right each. The Company does not hold any shares in treasury. The number of Ordinary Shares with voting rights is therefore 43,375,427.

Accordingly, these figures may be used by shareholders as a denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company, under the Disclosure and Transparency Rules.

For further information:

Science in Sport PLC

+44 (0) 20 7400 3700

Stephen Moon, CEO

Elizabeth Lake, Finance Director

 

Cenkos Securities - NOMAD and Broker

 

+44 (0) 20 7397 8900

Bobbie Hilliam

Yellow Jersey PR - Financial PR

Felicity Winkles

+44 (0) 7748 843 871

Harriet Jackson

+44 (0) 7544 275 882

Notes for editors

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2016 London Olympics, 34 medal-winning athletes or teams used SiS products (compared with 24 in 2012).

A key component of this trust is the Company's approach to preventing banned substances entering its supply chain and finished products. Each year an internal review of the banned substance prevention regime takes place, and from January 2017 an upgraded system has been implemented. The enhanced regime is built on the following pillars:

· Every single batch of SIS finished product which leaves the Company's factory is screened against the 2017 World Anti-Doping Agency (WADA) list. Banned substances including steroids are tested to the level of 10 Nanograms per gram, and stimulants to 100 Nanograms per gram

· Batches (sampled at the beginning, during and end of each product batch) receive the recognised and respected Informed Sport certificate and SIS provides the documentation to athletes on request

SiS is currently the official sports nutrition supplier to professional cycling team Team Sky, USA Cycling, British Cycling and Liverpool Football Club. Sir Chris Hoy & Katarina Johnson-Thompson are official brand ambassadors and cyclist Mark Cavendish is also an elite sports consultant.

The SiS core product range includes: SiS GO, comprising energy powders, isotonic gels, energy bars and hydration tablets, SiS REGO, including protein-based recovery powders and SiS Protein, products specifically designed to contribute to athletes' lean muscle mass growth and maintenance. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREAPDAESPXEEF
Date   Source Headline
11th Sep 20197:00 amRNSAppointment of Chief Financial Officer
8th Aug 20197:00 amRNSLaunch of SiS Plant Protein Range
31st Jul 20194:39 pmRNSNotification of Major Holdings
26th Jul 201912:27 pmRNSNotification of Major Holdings
25th Jul 20193:17 pmRNSNotification of Major Holdings
9th Jul 20197:00 amRNSHalf Year Trading Update
4th Jul 20195:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
28th Jun 20193:11 pmRNSNotification of Major Holdings
28th Jun 201911:35 amRNSNotification of Major Holdings
27th Jun 20194:15 pmRNSNotification of Major Holdings
27th Jun 201911:54 amRNSNotification of Major Holdings
27th Jun 20197:00 amRNSAGM Statement
25th Jun 20195:20 pmRNSNotification of Major Holdings
25th Jun 20195:15 pmRNSNotification of Major Holdings
12th Jun 20197:00 amRNSDirectorate Change
4th Jun 20197:00 amRNSOpens new e-commerce facility
24th May 20197:00 amRNSPosting of Annual Report & Notice of AGM
8th May 20197:00 amRNSPhD launches vegan Smart Bar Plant
2nd May 20197:00 amRNSSiS: Exclusive Nutrition Provider to Team INEOS
30th Apr 20197:00 amRNSLaunch of New PhD Website
3rd Apr 20194:28 pmRNSGrant of Options
27th Mar 201912:23 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSIssue of Equity
20th Mar 20197:00 amRNSFinal Results
4th Mar 20197:00 amRNSSiS: New Product Range for Footballers
27th Feb 20197:00 amRNSIssue of Equity
21st Feb 20197:00 amRNSSenior Management Appointments
29th Jan 20195:42 pmRNSHolding(s) in Company
21st Jan 20197:00 amRNSCapital Markets Day
14th Jan 20197:00 amRNSHolding(s) in Company
9th Jan 20197:00 amRNSPre-Close Trading Update
8th Jan 20191:10 pmRNSHolding(s) in Company
7th Jan 20192:00 pmRNSIssue of Equity
7th Dec 20185:15 pmRNSHolding(s) in Company
6th Dec 201812:15 pmRNSHolding(s) in Company
6th Dec 20188:01 amRNSCompletion of Acquisition
5th Dec 20185:09 pmRNSHolding(s) in Company - replacement
5th Dec 20185:00 pmRNSHolding(s) in Company
5th Dec 20184:58 pmRNSHolding(s) in Company
5th Dec 20184:48 pmRNSDirector/PDMR Shareholding
3rd Dec 201811:35 amRNSResult of General Meeting
16th Nov 20182:30 pmRNSHolding(s) in Company
14th Nov 20183:40 pmRNSResults of Placing
14th Nov 201811:05 amRNSSecond Price Monitoring Extn
14th Nov 201811:00 amRNSPrice Monitoring Extension
14th Nov 20187:00 amRNSProposed Acquisition & Placing
17th Oct 20187:00 amRNSLaunch into Chinese market
19th Sep 20187:00 amRNSHalf-year Report
13th Sep 201810:15 amRNSDirectorate Update
22nd Aug 20187:00 amRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.